Diatech Diabetes, Inc. implements innovative solutions to empower the lives of patients, families, and communities impacted by diabetes. Diatech originated from the issues our CEO was facing with his own diabetes care technology. Those who are affected by diabetes inspire us to work endlessly towards optimizing therapies for patients worldwide. Current insulin pump infusion sets and occlusion alarms can compromise a diabetic patient’s health during the occurrence of infusion site malfunctions. These malfunctions range from blocks, leaks, and infusing into damaged tissue affected by lipohypertrophy that may prevent insulin from being infused into the body properly. Diatech Diabetes is developing SmartFusion: a system for insulin pumps that monitors insulin delivery for accuracy and infusion set failure. When SmartFusion's software is integrated into an insulin pump system, our algorithm uses data from the pump, continuous glucose monitor, and patient to monitor the success of daily insulin dosages. SmartFusion’s features will include: - Alerts to other malfunctions such as leaks and improper insertion - Reviewable data on how infusion performance/habits affect diabetes control - Instant infusion failure alerts to connected devices - Custom settings to prevent alarm fatigue - Infusion set wear time recommendations - Personalized tips for healthy infusion based on habits These features could allow insulin pump users to know the exact time at which their infusion set needs to be changed and when infusion accuracy is lost to avoid potentially life-threatening blood sugar. For health care providers, SmartFusion allows for the collection of data related to infusion site health and characterizing malfunctions for each of their patients. This data could be uploaded through diabetes management platforms during check-ups and assist providers with ensuring their patients are accurately using insulin pump technology. SmartFusion is Not Currently Proven for Human Use.